Vaccine Therapy in Treating Patients With Stage IV Melanoma

Clinical trial NCT00023647 · COMPLETED

Trial details

NCT number: NCT00023647
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2000-07-01
Primary completion: 2002-04-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.